Deutsche Bank
DMAC icon

Deutsche Bank’s DiaMedica Therapeutics DMAC Stock Holding History

Deutsche Bank’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$192K Buy
28,354
+3,988
+16% +$31.6K ﹤0.01% 3020
2025
Q4 		$194K Sell
24,366
-8,401
-26% -$62.8K ﹤0.01% 3024
2025
Q3 		$225K Buy
+32,767
New +$178K ﹤0.01% 3009
2020
Q2 		– Sell
-551
Closed -$2K – 4289
2020
Q1 		$2K Buy
551
+534
+3,141% +$2.21K ﹤0.01% 4210
2019
Q4 		$0 Buy
+17
New +$53 ﹤0.01% 5010

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deutsche Bank's DMAC Position: Q1 2026 in Review

Deutsche Bank increased its DiaMedica Therapeutics (DMAC) stake by 16% in Q1 2026, buying an estimated $31.6K and bringing the position to 28,354 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

Deutsche Bank first reported a position in DMAC in Q4 2019 and has held it in 5 quarters since. The position peaked at $225K in Q3 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Deutsche Bank held 28,354 shares of DiaMedica Therapeutics worth $192K as of Q1 2026.
  • Deutsche Bank bought 3,988 DiaMedica Therapeutics shares in Q1 2026, an estimated $31.6K.
  • DiaMedica Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3020 holding.
  • Deutsche Bank first reported a position in DiaMedica Therapeutics in Q4 2019 and has held it in 5 quarters since.
  • Deutsche Bank's DiaMedica Therapeutics position peaked at $225K in Q3 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.